In CRC, DDX39B enhances PKM2 stabilization and nuclear translocation independently of ERK1/2-mediated phosphorylation, thereby driving the expression of oncogenes and glycolytic genes to accelerate tumor progression (37). This evidence concerns the gene PKM and neoplasm.